Csenge Advisory Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $554K | Buy |
1,738
+192
| +12% | +$61.2K | 0.03% | 404 |
|
|
2025
Q1 | $440K | Sell |
1,546
-245
| -14% | -$69.8K | 0.03% | 426 |
|
|
2024
Q4 | $632K | Sell |
1,791
-271
| -13% | -$95.6K | 0.03% | 371 |
|
|
2024
Q3 | $739K | Buy |
2,062
+295
| +17% | +$106K | 0.04% | 341 |
|
|
2024
Q2 | $563K | Buy |
1,767
+310
| +21% | +$98.8K | 0.03% | 375 |
|
|
2024
Q1 | $335K | Buy |
1,457
+23
| +2% | +$5.28K | 0.02% | 520 |
|
|
2023
Q4 | $315K | Sell |
1,434
-80
| -5% | -$17.6K | 0.02% | 511 |
|
|
2023
Q3 | $342K | Buy |
1,514
+195
| +15% | +$44K | 0.02% | 460 |
|
|
2023
Q2 | $291K | Buy |
1,319
+78
| +6% | +$17.2K | 0.02% | 508 |
|
|
2023
Q1 | $278K | Sell |
1,241
-87
| -7% | -$19.5K | 0.02% | 486 |
|
|
2022
Q4 | $369K | Buy |
+1,328
| New | +$369K | 0.03% | 417 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | -$1K | – | 1427 |
|
|
2018
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 937 |
|